Many thanks to MissPiggy for translating this article from the German news outlet N-TV:
Astrazeneca in focus again
Man dies after testing Corona vaccine
October 21, 2020
The EU has a contract with Astrazeneca for its supply of doses. Now, a volunteer has died in Brazil during a study by the pharmaceutical company on the Corona vaccine. Despite that, the tests will be continued on human subjects.
A test subject died during the study of a corona vaccine from the pharmaceutical company Astrazeneca in Brazil. This was confirmed by the Brazilian health watchdog, Anvisa. Earlier, Brazilian media reported on it. The vaccine was developed by the British-Swedish company in collaboration with the University of Oxford. According to the company, Anvisa had already been informed on Monday. The recommendation is to continue the tests. The case is currently under investigation and data on volunteers must be treated confidentially.
According to CNN Brasil, the dead man is a 28-year-old man from Rio de Janeiro who died from complications related to Covid-19. The Brazilian newspaper “O Globo”, however, reported, citing sources who did not want to be named for legal reasons, that the volunteer in question had received a placebo rather than the vaccine. Officially, neither the laboratory nor the test centres nor Anvisas commented on questions at first.
Astrazeneca had already temporarily halted clinical trials for its promising Corona vaccine in September and apparently not for the first time. The vaccine AZD1222 was thought to be one of the promising candidates among the potential Corona vaccines. If a link between the volunteer’s death and the vaccine emerges, it would be a major blow to the project.
The vaccine is currently being tested by the European Medicines Agency (EMA) in a so-called rolling review procedure. In this procedure, data from the clinical trial are submitted and evaluated on an ongoing basis. The EU has already concluded a framework agreement with Astrazeneca for the supply of dosages.